Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL - Phio Pharmaceuticals Corp. | phio_ex3101.htm |
| EX-32.1 - CERTIFICATION - Phio Pharmaceuticals Corp. | phio_ex3201.htm |
| EX-10.3 - FORM OF RESTRICTED STOCK UNIT AWARD - Phio Pharmaceuticals Corp. | phio_ex1003.htm |
| 10-K - FORM 10-K - Phio Pharmaceuticals Corp. | phio_10k-123120.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Phio Pharmaceuticals Corp.
Marlborough, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (No. 333-251670, 333-189521, 33-215871, 333-227013 and 333-230547) and Form S-3 (Nos. 333-224031 and 333-252588) of Phio Pharmaceuticals Corp. of our report dated March 25, 2021, relating to the consolidated financial statements, which appear in this Annual Report on Form 10-K.
/s/ BDO USA, LLP
Boston, Massachusetts
March 25, 2021